Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MariMed

Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?

For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.

Benzinga

Cronos Group (CRON) vs. MariMed (MRMD): Which Stock Are Investors Buying?

With evolving food consumption trends, favorable government policies and funding, and the adoption of cutting-edge technologies, the agricultural industry is well-placed to experience significant growth in the long run. So, let’s compare prominent agriculture stocks Cronos Group (CRON) and MariMed (MRMD) to identify which is gaining immense popularity among investors.…

StockNews.com

MariMed's Q3 Financial Results, Revenue Increases 3% Sequentially To $33.9M

MariMed, Inc. (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, recently announced its financial results for the third quarter that ended September 30, 2022.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022

Upgrades

Benzinga

MariMed Enriches Betty's Eddies Line With Cannabis Chews To Empower Libido, Reduce Stress, Improve Sleep & More

MariMed, Inc (CSE: MRMD), (OTCQX: MRMD) added new products to its top-selling Betty’s Eddies all-natural cannabis fruit chews brand.

Benzinga

What's Going On With Cannabis Pricing In Illinois? Analyst Examines Retailers' Menus

Illinois is one of the most prominent cannabis markets in the U.S. In 2022, recreational marijuana sales crossed the $1 billion mark.

Benzinga

EXCLUSIVE: How To Conquer The Midwest? 4Front, Pharmacann & Marimed Execs Discuss At Benzinga Cannabis Conference

Jon Levine, president of Marimed Inc., Brett Novey, CEO of Pharmacann and Andrew Thut, CIO of 4Front Ventures, operators in the Midwest and across the country, joined Barbara Webb, partner of MGO, and Steve Miles, CEO of Sharp Capi

Benzinga

Read news from The Economist, FT, and more,
with one subscription

MariMed Inc.: Existing Assets Have The Ability To Generate Over $350 million In Revenue Over Time

On August 8, MariMed, Inc. (OTC: MRMD) delivered second quarter 2022 financial results near the beginning of U.S. cannabis earnings season.

Benzinga

EXCLUSIVE: Dartmouth Engineering Students Conduct First-Ever Study On Energy Efficiency In Cannabis Cultivation

Dartmouth's Thayer School of Engineering and Arthur L. Irving Institute for Energy and Society announced the results of a first-of-its-kind independent study on energy efficiency in the cannabis industry.

Benzinga

MariMed Inc: Among A Select Few U.S. Cannabis Operators Generating Free Cash Flow And Positive Net Income

In a world where many U.S. cannabis multi-state operators (MSOs) laud the their ability to generate positive Adjusted EBITDA, MariMed, Inc. (OTC: MRMD) goes a couple of steps further.

Benzinga

MariMed To Launch Betty's Eddies Brand Into Maine Adult-Use Cannabis Marketplace

MariMed, Inc. (OTCQX: MRMD) entered into a licensing agreement with East Coast Cannabis Company.

Benzinga

MariMed Awarded Medical Cannabis Dispensary License In Ohio

MariMed Inc. (OTCQX: MRMD) had been awarded a provisional dispensary license by the Ohio Board of Pharmacy.

Benzinga

MariMed Reports Strong Q1, Provides 2022 Financial Guidance

MariMed, Inc. (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the first quarter ended March 31, 2022.

Benzinga

MariMed Closes Acquisition Of Illinois Craft Cannabis License, Here Is What You Need To Know

MariMed, Inc. (OTCQX: MRMD) has closed its acquisition of Green Growth Group, Inc.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

MariMed Completes Acquisition Of Kind Therapeutics USA, A Maryland Vertically Integrated Cannabis Business

MariMed Inc. (OTCQX: MRMD) completed the acquisition of Kind Therapeutics U.S.A., LLC.

Benzinga

Cannabis Stock Gainers And Losers From April 22, 2022

GAINERS: MariMed (OTC:MRMD) shares closed up 5.59% at $0.72

Benzinga

EXCLUSIVE: Why Cannabis Industry Consolidation 'In The Foreseeable Future' Is Most Likely To Continue

Growth can come through the acquisition of businesses at the grassroots level. “We are buying to continue to grow.”

Benzinga

EXCLUSIVE: MariMed's CEO On 'Making Love To The Plant'

MariMed Inc. (OTCQX: MRMD) is hoping to expand its presence into seven more states in the next 18 months.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Last-Minute Ideas For 4/20: 40 Products to Elevate Your Cannabis Day Celebrations

Every cannabis consumer’s favorite holiday is here. April 20th, or 4/20 as it’s called, is a holiday all about celebrating the plant, educating others on the benefits of cannabis, and most importantly: consuming cannabis.

Benzinga

MariMed Receives Maryland State Approval For Transfer Of Ownership Of Kind Therapeutics USA

Maryland Medical Cannabis Commission has approved the transfer of 100% of the ownership of Kind Therapeutics U.S.A., LLC, to MariMed Inc. (OTCQX: MRMD)

Benzinga

MariMed Files Preliminary Non-Offering Prospectus And Applies For Dual Listing On CSE

MariMed, Inc. (OTCQX:MRMD) has filed a preliminary non-offering long form prospectus with the securities regulatory authorities in the provinces of Ontario and British Columbia. No securities are being sold pursuant to the prospectus and no proceeds are being raised.

StockNews.com

4 Penny Stocks with Over 155% Upside Potential, According to Wall Street

After a tumultuous start to the year, the stock market appears to have stabilized somewhat. And with talks between Russia and Ukraine progressing, the stock market may bounce back on any positive developments. So, we think it could be wise to add penny stocks MariMed (MRMD), Exela Technologies (XELA), Inuvo…

Benzinga

MariMed Doubles Full Year Revenue And Adjusted EBITDA, Reports Q4 & Full Year Earnings

MariMed (OTCQX: MRMD), a leading multi-state cannabis operator, announced its financial and operating results for the fourth quarter and full year ended December 31, 2021.

Benzinga

MariMed Launches Vibations: High + Energy Cannabis-Infused Drink Mix

MariMed, Inc. (OTCQX: MRMD) launched Vibations: High + Energy, an all-natural, full-spectrum cannabis drink mix that provides focus and energy for the mind and body.

Benzinga

MariMed Expands Massachusetts Retail Footprint With Acquisition Of Cannabis Dispensary In Beverly

MariMed, Inc. (OTCQX: MRMD) has signed a definitive agreement to acquire a provisional dispensary license from Green House Naturals, LLC.

1 2

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

L3Harris Technologies

40 stories

Ascend

34 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.